oh ventura,Kennedy was never with Aphria, but if Aphria and Tilray had it figured out 10 years ago - why are they repporting a decrease in cannabis sales and market share - and a $1.5 BILLION NET LOSS 10 years later?
Curaleaf is the world;s largest cannabis company by revenue - $1.5 BILLION in sales, compared to Tilray;s $600,000. Following your logic, the Curaleaf CEO should be paid over 2x the $30 million Simple Simon sucks out of Tilray every year.
And while Tilray MAY have the largest market share in MEDICAL CANNABIS in Germany at 20% (they claim) - 20% of the German medical market just isn;t saying much. Curaleaf estimates it has 15-20% - and Curaleaf has the largest footrpint in Europe, not just in Germany.
Do you actually follow the cannabis sector - or just Tilray's news releases?
Regardless - your endless comparisons of Tilray to Curaleaf - or any other US MSO - are irrelevant to Tilray investors. Find something else to post about, I care less about Curaleaf, but readers might be getting bored with your posts.